Eliaz Therapeutics: Funding, Investors & Team (Sep 2026)
ETI have fostered a protected, novel clinical gadget that eliminates galectin-3 from human blood. The gadget eliminates both bound and free galectin-3 from the course, offering another treatment choice that is less obtrusive and has less aftereffects than different treatments. The single-use apheresis segment specifically eliminates Galectin-3 from the body. It contains an exclusive, profoundly powerful catching particle and is underlying an organization that medical clinics definitely know how to utilize.
Eliaz Therapeutics has raised $2.4M across 3 funding rounds on record, the most recent an Equity Crowdfunding of $40k announced in Jul 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Eliaz Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Eliaz Therapeutics Funding Rounds
Eliaz Therapeutics raised $1.7M in a Grant announced in Jun 2022.
3.9 years later, an undisclosed round of $640k was announced in May 2026.
2 months later, an Equity Crowdfunding of $40k was announced in Jul 2026.
Eliaz Therapeutics Investors
Eliaz Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Eliaz Therapeutics Funding Compared to Other Biotechnology Startups
Eliaz Therapeutics' latest round of $40k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eliaz Therapeutics in Biotechnology and Santa Rosa
Companies Similar to Eliaz Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Eliaz Therapeutics Funding FAQs
What does Eliaz Therapeutics do?
ETI have fostered a protected, novel clinical gadget that eliminates galectin-3 from human blood. The gadget eliminates both bound and free galectin-3 from the course, offering another treatment choice that is less obtrusive and has less aftereffects than different treatments. The single-use apheresis segment specifically eliminates Galectin-3 from the body. It contains an exclusive, profoundly powerful catching particle and is underlying an organization that medical clinics definitely know how to utilize.
How much funding has Eliaz Therapeutics raised?
Eliaz Therapeutics has raised $2.4M across 3 rounds on record. The most recent is an Equity Crowdfunding of $40k announced in Jul 2026.
When did Eliaz Therapeutics last raise funding?
Eliaz Therapeutics' most recent funding round on record is an Equity Crowdfunding of $40k, announced in Jul 2026.
Who has invested in Eliaz Therapeutics?
Investors on record for Eliaz Therapeutics include National Institutes of Health.
Who founded Eliaz Therapeutics?
FundedIQ lists Isaac Eliaz (Founder) at Eliaz Therapeutics.
Where is Eliaz Therapeutics headquartered?
Eliaz Therapeutics is based in Santa Rosa, California, United States.
How many employees does Eliaz Therapeutics have?
Eliaz Therapeutics is in the 1-10 employee band.
When was Eliaz Therapeutics founded?
Eliaz Therapeutics was founded in 2015.
How does Eliaz Therapeutics' funding compare to other Biotechnology startups?
Eliaz Therapeutics' latest round of $40k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Eliaz Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eliaz Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.